Literature DB >> 24472519

Effectiveness of 5-aminolevulinic acid photodynamic therapy in the treatment of hidradenitis suppurativa: a report of 5 cases.

R Andino Navarrete1, A Hasson Nisis1, J Parra Cares2.   

Abstract

Hidradenitis suppurativa has been described as a chronic, recurrent, and disabling inflammatory disease involving the entire hair follicle. Several treatments, including photodynamic therapy, have been used, but the results have been inconsistent and recurrence is high. In this prospective study, we evaluated disease severity, quality of life, and treatment tolerance in 5 patients with moderate to severe hidradenitis suppurativa treated with photodynamic therapy using 5-aminolevulinic acid and a 635-nm light source. Treatment effectiveness was evaluated using the Sartorius severity score, the Dermatology Life Quality Index, and a visual analog scale for pain and disease activity. Significant improvements were observed with all 3 instruments and the effects remained visible at 8 weeks. Our results suggest that photodynamic therapy with 5-aminolevulinic acid and a light wavelength of 635 nm could reduce disease severity and improve quality of life in patients with difficult-to-treat hidradenitis suppurativa.
Copyright © 2013 Elsevier España, S.L. y AEDV. All rights reserved.

Entities:  

Keywords:  5-aminolevulinic acid; Hidradenitis suppurativa; Hidrosadenitis supurativa; Photodynamic Therapy; Terapia fotodinámica; Ácido 5-aminolevulínico

Mesh:

Substances:

Year:  2014        PMID: 24472519     DOI: 10.1016/j.ad.2013.10.016

Source DB:  PubMed          Journal:  Actas Dermosifiliogr        ISSN: 0001-7310


  2 in total

Review 1.  Photodynamic Therapy and Skin Appendage Disorders: A Review.

Authors:  Matteo Megna; Gabriella Fabbrocini; Claudio Marasca; Giuseppe Monfrecola
Journal:  Skin Appendage Disord       Date:  2016-12-08

2.  Nodular-cystic eruption in course of sorafenib administration for hepatocarcinoma: An unconventional skin reaction requiring unconventional treatment.

Authors:  Francesco Borgia; Carlo Saitta; Mario Vaccaro; Maria Stella Franzè; Maria Lentini; Serafinella Patrizia Cannavò
Journal:  Int J Immunopathol Pharmacol       Date:  2017-08-21       Impact factor: 3.219

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.